U.S. market Closed. Opens in 1 day 2 hours 3 minutes

RDHL | RedHill Biopharma Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue6.51M61.80M85.76M64.36M6.29M8.36M4.01M101.00K3.00K7.01M12.00K16.00K23.00KN/A
Cost of Revenue3.46M33.34M49.41M36.89M2.26M2.84M2.13M30.54M22.00M1.05MN/AN/AN/AN/A
Gross Profit3.05M28.46M36.35M27.47M4.03M5.52M1.88M-30.44M-22.00M5.96M12.00K16.00K23.00KN/A
Operating Expenses-9.56M71.31M117.49M91.15M47.23M44.85M53.85M30.64M22.00M16.61M10.78M9.06M7.90M1.73M
Selling, General & Admin30.98M64.03M87.99M74.66M29.81M19.99M20.04M5.40M4.13M4.01M2.68M2.60M2.48M518.00K
Research & Development3.52M7.28M29.50M16.49M17.42M24.86M32.97M25.24M17.77M12.70M8.10M6.46M5.41M736.00K
Other Operating Expenses-44.06MN/AN/AN/AN/AN/A845.00KN/A100.00K-100.00KN/AN/AN/AN/A
Operating Income12.63M-42.84M-81.14M-63.68M-43.20M-39.33M-51.97M-30.54M-22.00M-10.65M-10.77M-9.04M-7.87M-1.73M
Other Expenses / Income11.32M-28.82M-16.61M-12.49M897.00K511.00K6.43M1.17M812.00K-64.00K144.00K-1.29M-7.63M-811.00K
Before Tax Income23.95M-71.67M-97.74M-76.17M-42.30M-38.82M-45.54M-29.37M-21.09M-10.71M-10.63M-10.33M-15.50M-2.54M
Income Tax ExpensesN/A-12.42M16.57M12.84M1.33M727.00K6.29M1.27M900.00K222.00K142.00K1.29M7.63M874.00K
Net Income23.92M-59.24M-114.31M-89.02M-43.63M-38.82M-45.54M-29.37M-21.09M-10.71M-10.63M-10.33M-15.50M-2.54M
Interest Expenses367.00K41.33M16.57M12.76M438.00K167.00K77.00K375.00K212.00K383.00K14.00K1.48M65.00K876.00K
Basic Shares Outstanding6.48M1.55M1.16M910.69K742.30K570.88K437.92K309.30K277.04K216.53K155.95K129.07K120.22K131.49K
Diluted Shares Outstanding6.48M1.55M1.16M910.69K742.30K570.88K437.92K319.24K279.29K218.06K155.95K131.49K120.22K131.49K
EBITDA26.31M-42.84M-63.03M-54.94M-40.78M-38.60M-45.79M-30.50M-21.87M-10.62M-10.75M-9.02M-7.86M-2.55M
EBITDA Margin403.94%-69.33%-73.50%-85.36%-648.30%-461.77%-1,142.63%-30,197.03%-728,866.67%-151.41%-89,566.67%-56,350.00%-34,165.22%0.00%
EBIT24.28M-30.34M-81.18M-63.41M-41.87M-37.93M-39.18M-27.72M-19.98M-10.11M-10.47M-7.56M-7.81M-794.00K
EBIT Margin372.83%-49.09%-94.66%-98.53%-665.49%-453.66%-977.84%-27,447.52%-665,933.33%-144.08%-87,266.67%-47,231.25%-33,947.83%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙